Evaluate FNAC of breast lesions using Yokohama classification and its correlation with BIRAD System
Not Applicable
- Conditions
- Health Condition 1: D249- Benign neoplasm of unspecified breastHealth Condition 2: C509- Malignant neoplasm of breast of unspecified siteHealth Condition 3: N609- Unspecified benign mammary dysplasiaHealth Condition 4: N630- Unspecified lump in unspecified breast
- Registration Number
- CTRI/2023/04/051241
- Lead Sponsor
- BPS GMC(W), Khanpur Kalan, Sonepat
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All the patients having breast lump whose both FNAC and BIRADS grading will be done
Exclusion Criteria
1. Patients with ulcerative lesion or skin involvement.
2. Patients with history of chemotherapy and radiotherapy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate FNAC of breast lesions using Yokohama classification and its correlation with the BIRAD system.Timepoint: 6 months, 1 year
- Secondary Outcome Measures
Name Time Method 1. To categorise FNAC smears of breast lump according to Yokohama system. <br/ ><br>2. To categorise the ultrasound findings of breast lump using USG based BIRAD <br/ ><br>system. <br/ ><br>3. To find concordance between Yokohama system and USG based BIRAD system for reporting breast lesions. <br/ ><br>Timepoint: 6 months, 1 year